0001104659-22-077703.txt : 20220706 0001104659-22-077703.hdr.sgml : 20220706 20220706161610 ACCESSION NUMBER: 0001104659-22-077703 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220701 FILED AS OF DATE: 20220706 DATE AS OF CHANGE: 20220706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sethuraman Natarajan CENTRAL INDEX KEY: 0001873394 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40969 FILM NUMBER: 221068893 MAIL ADDRESS: STREET 1: 6 TIDE STREET CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Entrada Therapeutics, Inc. CENTRAL INDEX KEY: 0001689375 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813983399 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6 TIDE STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-305-1825 MAIL ADDRESS: STREET 1: 6 TIDE STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: CycloPorters, Inc. DATE OF NAME CHANGE: 20161104 4 1 tm2220515-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-07-01 0 0001689375 Entrada Therapeutics, Inc. TRDA 0001873394 Sethuraman Natarajan C/O ENTRADA THERAPEUTICS, INC. 6 TIDE STREET BOSTON MA 02210 0 1 0 0 Chief Scientific Officer Stock Option (Right to Buy) 12.00 2022-07-01 4 A 0 34763 0 A 2032-07-01 Common Stock 34763 34763 D 25% of the option shares shall vest and become exercisable on July 1, 2023, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, such that the option shares will be fully vested on July 1, 2026. /s/ Jared Cohen, as Attorney-in-Fact 2022-07-06